Related Experiment Video

Updated: Jun 11, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Exploiting liver immunity for the prevention of hepatic metastases

Licia Rivoltini, Vincenzo Mazzaferro

    Journal of Hepatology
    |July 9, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury05:59

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

    Published on: August 30, 2019

    A Preclinical Murine Model of Hepatic Metastases06:51

    A Preclinical Murine Model of Hepatic Metastases

    Published on: September 27, 2014

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.